We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
-0.35%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$1.59B
AUM Growth
+$469M
Cap. Flow
+$491M
Cap. Flow %
30.91%
Top 10 Hldgs %
26.26%
Holding
2,828
New
215
Increased
1,024
Reduced
629
Closed
413
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRME icon
2676
Prime Medicine
PRME
$508M
-139
Closed -$538
PRVA icon
2677
Privia Health
PRVA
$3B
-69
Closed -$1.26K
PTLO icon
2678
Portillo's
PTLO
$329M
-146
Closed -$1.97K
PVH icon
2679
PVH
PVH
$4.09B
-77
Closed -$7.76K
PWZ icon
2680
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.15B
-339
Closed -$8.5K
QCRH icon
2681
QCR Holdings
QCRH
$1.71B
-14
Closed -$1.04K
QS icon
2682
QuantumScape Corp
QS
$3.28B
-385
Closed -$2.21K
REI icon
2683
Ring Energy
REI
$320M
-4,183
Closed -$6.69K
RELX icon
2684
RELX
RELX
$63.1B
-54
Closed -$2.56K
RENT
2685
Rent the Runway
RENT
$126M
-36
Closed -$348
RES icon
2686
RPC Inc
RES
$1.28B
-530
Closed -$3.37K
REVG
2687
DELISTED
REV Group
REVG
-273
Closed -$7.66K
REX icon
2688
REX American Resources
REX
$1.42B
-218
Closed -$5.05K
RGNX icon
2689
Regenxbio
RGNX
$638M
-23
Closed -$242
RKLB icon
2690
Rocket Lab Corp
RKLB
$44B
-33
Closed -$322
RLAY icon
2691
Relay Therapeutics
RLAY
$4.09B
-372
Closed -$2.63K
RMR icon
2692
The RMR Group
RMR
$322M
-2
Closed -$51
RNAM
2693
DELISTED
Avidity Biosciences
RNAM
-88
Closed -$4.04K
RNAC icon
2694
Cartesian Therapeutics
RNAC
$231M
-12
Closed -$194
ROCK icon
2695
Gibraltar Industries
ROCK
$1.37B
-108
Closed -$7.55K
ROOT icon
2696
Root
ROOT
$903M
-800
Closed -$30.2K
RTO icon
2697
Rentokil
RTO
$12B
-55
Closed -$1.36K
RYAN icon
2698
Ryan Specialty Holdings
RYAN
$5.65B
-9
Closed -$598
RYN icon
2699
Rayonier
RYN
$6.48B
-91
Closed -$2.67K
SAGE
2700
DELISTED
Sage Therapeutics
SAGE
-97
Closed -$701

Similar funds

Arax Advisory Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Arax Advisory Partners held 2,828 positions worth $1.59B, up 42% from $1.12B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Arax Advisory Partners deployed $491M of net new capital in Q4 2024, opening 215 new positions and adding to 1,024 existing holdings. Its largest new stake was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, up from 5.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Mid-Cap Value ETF, an estimated $3.07M trimmed.

  • Arax Advisory Partners's largest Q4 2024 buy was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.
  • Arax Advisory Partners added most to Vanguard Morningstar Growth ETF in Q4 2024, an estimated $33.3M increase.
  • Arax Advisory Partners's biggest Q4 2024 reduction was Vanguard Morningstar Mid-Cap Value ETF, cutting an estimated $3.07M.
  • Arax Advisory Partners fully exited WillScot Mobile Mini Holdings in Q4 2024, selling an estimated $508K.
  • Arax Advisory Partners's ten largest holdings make up 26% of its $1.59B portfolio in Q4 2024.
  • Arax Advisory Partners opened 215 new positions and closed 413 in Q4 2024.
  • Arax Advisory Partners's portfolio value rose 42% quarter-over-quarter to $1.59B.

Based on Arax Advisory Partners's 13F filing for Q4 2024, filed 5 Feb 2025.